All articles tagged with #abortion pill
The FDA approved a new generic version of the abortion pill mifepristone, prompting criticism from anti-abortion groups and Republican politicians, amid ongoing political and legal debates over abortion access in the U.S.
The FDA approved a generic version of the abortion pill mifepristone, sparking outrage among anti-abortion groups who oppose expanded access, despite extensive evidence supporting the drug's safety and efficacy. The approval is seen as a victory for evidence-based medicine by supporters, amid ongoing political and legal debates.
The FDA quietly approved a second generic version of the abortion pill mifepristone from Evita Solutions, just before a government shutdown, amid ongoing debates over its safety and access, with strong support from reproductive health advocates and opposition from anti-abortion groups.
Costco has decided not to sell the abortion pill mifepristone at its pharmacies, citing lack of demand and aligning with a conservative religious coalition that praised the decision, amidst ongoing debates over abortion access in the U.S.
Costco has decided to stop selling the abortion pill mifepristone in all its U.S. stores due to low demand, amid ongoing political and social debates surrounding the medication, which is used for medical abortions and is still dispensed by some other retailers in states where abortion is legal.
Costco has decided not to sell the abortion pill mifepristone at its pharmacies, influenced by religious activists and conservative groups, while other retailers like CVS and Walgreens continue to dispense it in states where it is legal. The decision highlights ongoing political and legal battles over access to reproductive health medications in the US.
Étienne-Émile Baulieu, a French biochemist renowned for developing the abortion pill RU-486 and advancing hormone research, has died at 98. His work significantly impacted reproductive health and aging studies, despite facing controversy and opposition. Baulieu was a passionate advocate for women's rights and scientific progress, receiving numerous honors including France's Grand Cross of the Legion of Honor.
A Massachusetts man, Robert Kawada, has been charged with secretly giving his girlfriend an abortion pill, Misoprostol, to end her pregnancy. Kawada allegedly deceived her by claiming the pills were iron supplements and even staged a fake call from a nurse to convince her. He faces multiple charges, including poisoning and assault, and is being held on $100,000 bail. The case is under investigation by the Middlesex District Attorney's Office and Watertown Police.
The Supreme Court heard arguments in a case that could reinstate restrictions on the abortion pill mifepristone, with conservative justices invoking the Comstock Act, a 1873 law that made it illegal to send obscene materials through mail, including drugs that induce abortions and contraception. The law's scope has been narrowed over the years, but it has resurfaced in attempts to restrict mailed reproductive drugs. The case questions whether federal regulators overstepped their authority by loosening mifepristone restrictions, and a decision is expected later this summer, potentially impacting the 2024 presidential election.
The Supreme Court heard arguments challenging the FDA's relaxed regulations on the abortion pill, with legal experts suggesting the case may be dismissed due to lack of standing. Justices appeared skeptical of the FDA's lack of accountability for any harms caused by the pill, with Justice Alito questioning the FDA's infallibility and whether anyone can sue in such cases. The questioning may indicate the justices' thinking on who has standing in such matters, with implications for future legal challenges.
The Supreme Court is considering a challenge to the abortion pill mifepristone, focusing on whether doctors have legal standing to object to treating patients with complications from the drug based on conscience objections. Justices questioned whether the doctors' conscience objections were lacking, as federal law already allows doctors to raise such objections in abortion-related contexts. The court's decision could hinge on whether the doctors can already bring conscience objections, potentially avoiding ruling on the legality of the FDA's decision to lift restrictions on mifepristone. Only two of the seven doctors specifically raised conscience concerns, with the court scrutinizing their objections and the nature of their involvement in abortion procedures.
The US Supreme Court appears unlikely to limit access to the abortion pill as it hears arguments in an appeal by President Joe Biden's administration of a lower court's ruling in favor of anti-abortion groups and doctors challenging the drug's prescription and distribution. Justices expressed skepticism about the plaintiffs' legal standing to pursue the case, with conservative members highlighting existing federal laws protecting medical personnel from being forced to perform or assist in abortions. The case, which places reproductive rights back on the Supreme Court's agenda in a presidential election year, is expected to have a ruling by the end of June.
Erin Hawley, a law professor and wife of Senator Josh Hawley, is at the center of a Supreme Court case involving nationwide limits on abortion access, arguing to sharply curtail access to the abortion pill. Representing a group of anti-abortion doctors and conservative medical associations, she claims the abortion pill is a danger to women, while the FDA points to substantial scientific evidence of its safety.
The Supreme Court appeared skeptical of efforts to restrict access to mifepristone, a key medication used in over 60% of U.S. abortions, as it heard a case challenging the government's loosening of regulations. Justices questioned whether the antiabortion doctors challenging the regulations have sufficient legal grounds to bring the lawsuit. The case comes less than two years after the conservative majority overturned Roe v. Wade. Mifepristone, approved by the FDA for use through 10 weeks' gestation, is one of two drugs that work together to terminate a pregnancy. The pharmaceutical industry has warned that second-guessing the FDA's determinations in this case could disrupt the nation's drug-approval process and stymie private investments in drug research.
The Supreme Court is hearing arguments regarding the FDA's recent actions to make the abortion pill mifepristone more accessible, with potential implications for abortion access nationwide. The case involves challenges to the FDA's 2016 and 2021 changes, which allowed for easier access to the medication. The court's decision, expected by the end of June, could impact access to mifepristone and medication abortions across the country.